GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the first bromodomain (BD1) of human BRD2 bound to ERK5-IN-1

Analyse Crystal structure of the first bromodomain (BD1) of human BRD2 bound to… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7LAU
Type
protein
Length
108 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.4
Source
Homo sapiens
Molecule
Bromodomain-containing protein 2
UniProt
U3KQA6
Ligands
VYJ
Pockets
1 · best druggability 0.46

Structure

x-ray diffraction · resolution 2.4 · 1 distinct chain · 65% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 2protein10865% helix, 0% strandU3KQA6

Ligands and binding sites

  • VYJ · 11-cyclopentyl-2-({2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1930.460.8018VYJ

Compared structures

  • 7LAU · Crystal structure of the first bromodomain (BD1) of human BRD2 bound to ERK5-in-1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.